ml SCF. This was incubated for 48 hours at 37(C in 3. Williams, D., et al., Cell, 63, 167 (1990).
a 5% CO humidified incubator and then pulsed for 42
hours with H-thymidine. Cells were harvested onto3
probe
combination combinations combinations
Number of genes/assays 63/72 56/56 5/10 2/6
Combination with one reference gene 52 48 3 1
Combination with two reference genes 10 8 2 0
Combination with three
poudre, Belg. J. Food
Chem. Biotechnol., 42, 75 (1987)
2. F. Rappaport, et al., J. Clin. Pathol., 9, 261 (1956)
3. F. Rappaport, et al., Appl. Microbiol., 7, 63 (1959)
mL/g)
XAD-2 9060-05-3 Hydrophobic polyaromatic (dipole moment 0.3)
Used to remove hydrophobic compounds up to
20,000 MW
1.07
(1.02)
330 90 20 to 60 0.65
XAD-4 37380-42-0 Hydrophobic polyaromatic
XAD-2 9060-05-3 Hydrophobic polyaromatic (dipole moment 0.3)
Used to remove hydrophobic compounds up to
20,000 MW
1.07
(1.02)
330 90 20 to 60 0.65
XAD-4
cytoplasmic membrane via the
N-terminal region of ribonuclease E. Proc. Natl.
Acad. Sci. USA, 98, 63-68 (2001).
3. Rott, R., et al., RNA polyadenylation and
degradation in cyanobacteria are similar to the
(1990).
6 Jahoda, C., et al., J. Cell Sci., 99, 627 (1991).
7. Sappino, A., et al., Lab. Invest., 63, 144 (1990).
8. Ruzicka, D., et al., J. Cell Biol., 107, 2575 (1988).
9. Babai, F., et al., Differentiation
Future, 25, 63-71 (2000).
2. Justice, M.C., et al., Elongation factor 2 as a novel
target for selective inhibition of fungal protein
synthesis. J. Biol. Chem., 273, 3148-3151 (1998).
3. Gomez-Lorenzo
41 (2017).
42. Smolenski, Grant Alan, “The bovine teat canal: Its
role in pathogen recognition and defence of the
mammary gland”. University of Waikato, Ph.D.
dissertation, p. 63 (2018).
43.
XAD-2 9060-05-3 Hydrophobic polyaromatic (dipole moment 0.3)
Used to remove hydrophobic compounds up to
20,000 MW
1.07
(1.02)
330 90 20 to 60 0.65
XAD-4
CH3OH)x. Inorg. Chem., 42(1),
228-234 (2003).
8. Svensson, R., et al., Characterisation of polymeric
surfactants that are glutathione transferase
mimics. Toxicology, 168(3), 251-258 (2001).
Hypertens.
Rep., 12(3), 170-5 (2010).
3. Chamsi-Pasha, M. et al., Angiotensin-
Converting Enzyme 2 as a Therapeutic
Target for Heart Failure. Curr. Heart Fail.
Rep., 11(1), 58–63 (2014).
FLAG
.,
19(3), 1021-1030 (1978).
6. Aimoto, S., et al., Amino-acid sequence of a heat-
stable enterotoxin produced by human
enterotoxigenic Escherichia coli. Eur. J. Biochem.,
129(2), 2572-63 (1982).
children: heterogeneity
owing to diagnostic subtype and severity., Am. J.
Hum. Genet., 63, 1767-1776 (1998).
3. Haycock, J.W., et al., Marked disparity between
age-related changes in dopamine and
children: heterogeneity
owing to diagnostic subtype and severity., Am. J.
Hum. Genet., 63, 1767-1776 (1998).
3. Haycock, J.W., et al., Marked disparity between
age-related changes in dopamine and